ReviewFrontiers in pharmacology2025

Leveraging artificial intelligence to validate traditional biomarkers and drug targets in liver cancer recovery: a mini review.

Shengjian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.